These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8613488)

  • 21. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
    Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
    J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus.
    Vacheron S; Luther SA; Acha-Orbea H
    J Immunol; 2002 Apr; 168(7):3470-6. PubMed ID: 11907107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superantigens of mouse mammary tumor virus.
    Acha-Orbea H; MacDonald HR
    Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial stages of mammary tumor virus infection are superantigen independent.
    Pobezinskaya Y; Chervonsky AV; Golovkina TV
    J Immunol; 2004 May; 172(9):5582-7. PubMed ID: 15100301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.
    Golovkina TV; Prescott JA; Ross SR
    J Virol; 1993 Dec; 67(12):7690-4. PubMed ID: 8230492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice.
    Pucillo CE; Palmer LD; Hodes RJ
    Immunol Res; 1995; 14(1):58-68. PubMed ID: 7561341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.
    Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H
    J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to MMTV infection.
    Acha-Orbea H; Shakhov AN; Finke D
    Front Biosci; 2007 Jan; 12():1594-609. PubMed ID: 17127406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrovirus-host interactions. The mouse mammary tumor virus model.
    Acha-Orbea H
    Medicina (B Aires); 1997; 57 Suppl 2():43-52. PubMed ID: 9567343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes.
    Czarneski J; Berguer P; Bekinschtein P; Kim DC; Hakimpour P; Wagner N; Nepomnaschy I; Piazzon I; Ross SR
    Eur J Immunol; 2002 Apr; 32(4):945-56. PubMed ID: 11920560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
    Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I; Buggiano V; Goldman A; Piazzon I
    Medicina (B Aires); 1997; 57(2):235-44. PubMed ID: 9532836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.
    Marrack P; Winslow GM; Choi Y; Scherer M; Pullen A; White J; Kappler JW
    Immunol Rev; 1993 Feb; 131():79-92. PubMed ID: 8387458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products.
    Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB
    J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function.
    Held W; Waanders GA; Acha-Orbea H; MacDonald HR
    J Exp Med; 1994 Dec; 180(6):2347-51. PubMed ID: 7525852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.